Medicine and Dentistry
Disease
77%
COVID-19 Vaccine
73%
COVID-19 Vaccination
66%
Side Effect
63%
Cross Sectional Study
56%
Comorbidity
56%
Messenger RNA
52%
Prevalence
44%
Posttraumatic Stress Disorder
44%
Infection
40%
Coronavirinae
40%
Virus Infection
33%
Cariprazine
33%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Sympathetic Blocking
33%
Central Nervous System
33%
Generalized Anxiety Disorder
33%
Major Depressive Episode
33%
Liver Injury
33%
Parasympatholytic
33%
Catatonic Schizophrenia
33%
Stupor
33%
Somatics
33%
Treatment-Resistant Schizophrenia
33%
Emotional Stress
33%
Disease Predisposition
33%
Psychosis
33%
COVID-19
23%
Marital Status
23%
Compulsive Behavior
22%
Delusion
22%
Mood Disorder
22%
Self-Diagnosis
20%
Anxiety Disorder
19%
Typical Antipsychotic
17%
Social Interaction
17%
Drug Therapy
17%
Drug Dose Reduction
16%
Prodromal Symptom
16%
Catatonia
16%
Social Isolation
16%
Visual Analog Scale
13%
Virus Vector
13%
Schizoid Personality Disorder
11%
Paranoid Personality Disorder
11%
Psychological Evaluation
11%
Laboratory Test
11%
Spectrum Disorder
11%
Meta-Analysis
11%
Negative Syndrome
11%
Pharmacology, Toxicology and Pharmaceutical Science
COVID-19 Vaccine
83%
Side Effect
83%
Messenger RNA
72%
Bipolar Disorder
66%
Major Depression
66%
Disease
42%
Treatment-Resistant Schizophrenia
33%
Catatonic Schizophrenia
33%
Psychosis
33%
Inflammatory Bowel Disease
33%
Viral Vector
33%
Cariprazine
33%
Disease Predisposition
33%
Stupor
33%
Cholinergic Receptor Blocking Agent
33%
Posttraumatic Stress Disorder
33%
Pandemic
27%
Typical Antipsychotic
27%
Antipsychotic
27%
Compulsion
22%
Catatonia
16%
Coronavirinae
16%
Comorbidity
16%
Infection
16%
Prodromal Symptom
16%
Vaccination Reaction
16%
Leukocytosis
16%
Atypical Antipsychotics
16%
C Reactive Protein
16%
Clinical Feature
16%
Cross-Sectional Study
16%
Schizoidism
11%
Prevalence
11%
Ethanol
11%
Remission
11%
Positive Syndrome
11%
Negative Syndrome
11%
Polypharmacy
11%
Autonomic Dysfunction
5%
Olanzapine
5%
Tolerability
5%
Clinical Study
5%
Ropivacaine
5%
Nursing and Health Professions
Quality of Life
100%
Practice Guideline
66%
Hospital Readmission
66%
Disease
42%
Cross-Sectional Study
41%
Hamilton Depression Rating Scale
33%
Depression
33%
Inflammatory Bowel Disease
33%
Comorbidity
33%
Self Evaluation
29%
Visual Analog Scale
16%
Outpatient
14%
Patient with Inflammatory Bowel Disease
14%
Isoprenaline
11%
Depressive Disorder
11%
Clinical Practice
9%
Major Depression
9%
Bipolar Disorder
9%
Nonparametric Test
8%
World Health Organization
8%
Confounding Factor
8%
Marital Status
8%
Quality of Life Assessment
8%
